Carson Wealth (CWM LLC)
NRXP icon

Carson Wealth (CWM LLC)’s NRX Pharmaceuticals NRXP Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$4K Hold
32
– – ﹤0.01% 2456
2021
Q1 		$4K Hold
32
– – ﹤0.01% 2456
2020
Q4 		$4K Hold
32
– – ﹤0.01% 2455
2020
Q3 		$4K Hold
32
– – ﹤0.01% 2455
2020
Q2 		$4K Hold
32
– – ﹤0.01% 2455
2020
Q1 		$4K Hold
32
– – ﹤0.01% 2455
2019
Q4 		$4K Hold
32
– – ﹤0.01% 2454
2019
Q3 		$4K Hold
32
– – ﹤0.01% 2454
2019
Q2 		$4K Hold
32
– – ﹤0.01% 2454
2019
Q1 		$4K Buy
+32
New +$3.29K ﹤0.01% 2452

Other funds holding NRXP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HAG
HighPoint Advisor Group Downers Grove, Illinois $2.39B AUM 28.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Carson Wealth (CWM LLC)'s NRXP Position: Q2 2021 in Review

Carson Wealth (CWM LLC) held its NRX Pharmaceuticals (NRXP) position steady in Q2 2021 at 32 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #2456.

Carson Wealth (CWM LLC) first reported a position in NRXP in Q1 2019 and has held it in 10 quarters since. 18 funds tracked by Wall St. Rank hold NRXP as of Q2 2021.

  • Carson Wealth (CWM LLC) held 32 shares of NRX Pharmaceuticals worth $4K as of Q2 2021.
  • Carson Wealth (CWM LLC) left its NRX Pharmaceuticals share count unchanged in Q2 2021.
  • NRX Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q2 2021, its #2456 holding.
  • Carson Wealth (CWM LLC) first reported a position in NRX Pharmaceuticals in Q1 2019 and has held it in 10 quarters since.
  • 18 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q2 2021.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q2 2021, filed 29 Jul 2021.